Crescita Therapeutics Announces the Results of its Annual General and Special Meeting of Shareholders
June 21 2023 - 6:30AM
Business Wire
Crescita Therapeutics Inc. (TSX: CTX and OTC US:
CRRTF) (“Crescita” or the “Company”), a growth-oriented,
innovation-driven Canadian commercial dermatology company, today
announced the voting results from its Annual General and Special
Meeting of Shareholders held at its corporate headquarters in
Laval, Quebec on June 20, 2023. The detailed results of the votes
received by proxy are as follows:
Election of Directors
Director Nominees
NUMBER OF SHARES
PERCENTAGE OF VOTES
CAST
FOR
WITHHELD
FOR
WITHHELD
Daniel N. Chicoine
4,113,511
91,743
97.8%
2.2%
Anthony E. Dobranowski
3,549,815
655,439
84.4%
15.6%
John C. London
3,550,494
654,760
84.4%
15.6%
Deborah Shannon-Trudeau
4,115,644
89,610
97.9%
2.1%
Serge Verreault
3,550,534
654,720
84.4%
15.6%
Appointment of External Auditors
Outcome
NUMBER OF SHARES
PERCENTAGE OF VOTES
CAST
FOR
WITHHELD
FOR
WITHHELD
Ernst & Young LLP
reappointed
4,965,906
47,466
99.1%
0.9%
Consideration of a Special Resolution Approving a Change of
the Municipality of Crescita’s Registered Office
Outcome
NUMBER OF SHARES
PERCENTAGE OF VOTES
CAST
FOR
AGAINST
FOR
AGAINST
Change of municipality
approved
4,181,460
23,794
99.4%
0.6%
About Crescita Therapeutics Inc.
Crescita (TSX: CTX and OTC US: CRRTF) is a growth-oriented,
innovation-driven Canadian commercial dermatology company with
in-house R&D and manufacturing capabilities. The Company offers
a portfolio of high-quality, science-based non-prescription
skincare products and early to commercial stage prescription
products. We also own multiple proprietary transdermal delivery
platforms that support the development of patented formulations to
facilitate the delivery of active ingredients into or through the
skin. For further details, visit www.crescitatherapeutics.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230621953997/en/
FOR MORE INFORMATION, PLEASE CONTACT: Investor Relations
Linda Kisa, CPA, CA Email: lkisa@crescitatx.com
Crescita Therapeutics (TSX:CTX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Crescita Therapeutics (TSX:CTX)
Historical Stock Chart
From Apr 2023 to Apr 2024
